BDBM37557 1-(4-ethylthieno[3,2-b]pyrrol-5-yl)carbonyl-N-(3-phenylpropyl)piperidine-3-carboxamide::1-(4-ethylthieno[3,2-b]pyrrole-5-carbonyl)-N-(3-phenylpropyl)nipecotamide::1-(4-ethylthieno[3,2-b]pyrrole-5-carbonyl)-N-(3-phenylpropyl)piperidine-3-carboxamide::1-[(4-ethyl-4H-thieno[3,2-b]pyrrol-5-yl)carbonyl]-N-(3-phenylpropyl)piperidine-3-carboxamide::1-[(4-ethyl-5-thieno[3,2-b]pyrrolyl)-oxomethyl]-N-(3-phenylpropyl)-3-piperidinecarboxamide::MLS000093513::SMR000029131::cid_3235839
SMILES CCn1c(cc2sccc12)C(=O)N1CCCC(C1)C(=O)NCCCc1ccccc1
InChI Key InChIKey=WCWAVFAPFPKZMA-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 37557
TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Affinity DataIC50: >4.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair